C4 Therapeutics (CCCC) Research & Development (2019 - 2026)
C4 Therapeutics' Research & Development was $24.47 million in Q2 2026, down 6.6% from $26.2 million a year earlier and down 0.5% from the prior quarter.
Powered by 
Analysis
C4 Therapeutics (CCCC) Research & Development (2019 - 2026) Analysis & Trends
On a trailing twelve-month basis, C4 Therapeutics' Research & Development was $100.05 million through Jun 30, 2026, down 14.9% year-over-year; for FY2025, it was $104.24 million, down 5.8% from FY2024.
- Research & Development has now declined for three consecutive years, though with a five-year compound annual growth rate of 5.9% (FY2020 to FY2025).
- In earlier years, Research & Development was $110.64 million in FY2024 (-6.0%), $117.71 million in FY2023 (-0.1%), $117.84 million in FY2022 (+24.5%) and $94.67 million in FY2021 (+20.7%).
- The Q2 2026 figure marks the lowest quarterly Research & Development since Q2 2024.
- Compared with a year earlier, Research & Development has declined for four straight quarters, with an average decline of 0.9% over the last eight quarters.
- The best year-over-year quarter for Research & Development over five years was Q2 2022 (growth of 34.5%); the worst was Q4 2025 (a decline of 23.2%).
- Per Business Quant data, CCCC's Research & Development in the three quarters before Q2 2026 was $24.61 million (Q1 2026), $24.98 million (Q4 2025) and $25.99 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 3.65 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 2.34 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 9.74 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | -2.85 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | -4.05 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 1.87 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 1.76 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 2.81 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 993.80 Mn |
| 10 | C4 Therapeutics | 383.47 Mn | -546.29 Mn | - | 24.47 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 24.47 Mn |
| Mar 31, 2026 | 24.61 Mn |
| Dec 31, 2025 | 24.98 Mn |
| Sep 30, 2025 | 25.99 Mn |
| Jun 30, 2025 | 26.20 Mn |
| Mar 31, 2025 | 27.07 Mn |
| Dec 31, 2024 | 32.51 Mn |
| Sep 30, 2024 | 31.84 Mn |
| Jun 30, 2024 | 23.75 Mn |
| Mar 31, 2024 | 22.53 Mn |
| Dec 31, 2023 | 30.39 Mn |
| Sep 30, 2023 | 28.35 Mn |
| Jun 30, 2023 | 29.93 Mn |
| Mar 31, 2023 | 29.04 Mn |
| Dec 31, 2022 | 30.65 Mn |
| Sep 30, 2022 | 29.66 Mn |
| Jun 30, 2022 | 31.32 Mn |
| Mar 31, 2022 | 26.20 Mn |
| Dec 31, 2021 | 26.55 Mn |
| Sep 30, 2021 | 24.30 Mn |
API Access
C4 Therapeutics Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=CCCC&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "CCCC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=CCCC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();